Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Wolff

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Bone Marrow Transplantation|September 6, 2001
Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysisM Vusirikala, S N Wolff, R S Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantationC R Nichols, G Tricot, S D Williams, et al.
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Leukemia & Lymphoma|July 1, 1996
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
Seminars in Oncology|February 1, 1990
High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studiesS N Wolff, R H Herzig, J W Fay, et al.
Bone Marrow Transplantation|March 30, 2001
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic studyS N Wolff, R Herzig, J Lynch, et al.
Journal for Immunotherapy of Cancer|November 18, 2025
CAR-T cell therapy targeting MUC17 in gastric tumorsSangwoo Park, Cassidy E Ho, Filippo Birocchi, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Bone Marrow Transplantation|September 6, 2001
Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysisM Vusirikala, S N Wolff, R S Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantationC R Nichols, G Tricot, S D Williams, et al.
Blood|March 1, 1995
High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Leukemia & Lymphoma|July 1, 1996
High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant GroupR A Brown, S N Wolff, J W Fay, et al.
Leukemia & Lymphoma|November 8, 2001
Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapyR S Stein, S N Wolff, J P Greer, et al.
Cancer|July 15, 1991
Results of treatment with high intensity, brief duration chemotherapy in poor prognosis non-Hodgkin's lymphomaM L McMaster, J P Greer, S N Wolff, et al.
Seminars in Oncology|February 1, 1990
High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studiesS N Wolff, R H Herzig, J W Fay, et al.
Bone Marrow Transplantation|March 30, 2001
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic studyS N Wolff, R Herzig, J Lynch, et al.
Journal for Immunotherapy of Cancer|November 18, 2025
CAR-T cell therapy targeting MUC17 in gastric tumorsSangwoo Park, Cassidy E Ho, Filippo Birocchi, et al.
Pageof 18